Search results for "PARKINSON"

showing 10 items of 451 documents

Assessment of Functional Activities in Individuals with Parkinson’s Disease Using a Simple and Reliable Smartphone-Based Procedure

2020

Parkinson&rsquo

030506 rehabilitationmedicine.medical_specialtyParkinson's diseaseFunctional impairmentHealth Toxicology and MutagenesisParkinson's diseasefunctional mobilitylcsh:Medicinesmartphonegaitpostural controlArticlePostural control03 medical and health sciences0302 clinical medicineGait (human)Physical medicine and rehabilitationmedicineHumansPostural BalanceGaitGait Disorders NeurologicBalance (ability)Monitoring Physiologicbusiness.industryinertial measurement unitParkinson’s disease functional mobility gait inertial measurement unit postural control smartphonelcsh:RPublic Health Environmental and Occupational HealthPostural controlParkinson DiseaseProgressive neurodegenerative disordermedicine.diseasenervous system diseasesInertial measurement unitFunctional mobilityParkinson’s diseaseFunctional activitySmartphone0305 other medical sciencebusiness030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Mechanical Plantar Foot Stimulation in Parkinson′s Disease: A Scoping Review

2020

Background: Parkinson′s disease (PD) is the second most prevalent neurodegenerative disease in older individuals. Neurorehabilitation-based interventions such as those improving gait are crucial for a holistic approach and to limit falls. Several studies have recently shown that mechanical plantar foot stimulation is a beneficial intervention for improving gait impairment in PD patients. The objective of this scoping review is to evaluate the beneficial effects of this stimulation on gait parameters, and to analyse protocols of foot stimulation and other effects in non-motor symptoms. Relevant articles were searched in the Medline database using Pubmed and Scopus, using the primary search t…

030506 rehabilitationmedicine.medical_specialtyParkinson's diseasemedicine.medical_treatmentlcsh:MedicineStimulationReviewDiseasegaitrehabilitation03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicinestride lengthNeurorehabilitationRehabilitationmedical devicebusiness.industrylcsh:R3D printingmedicine.diseaseGaitClinical trialPreferred walking speedfoot0305 other medical sciencebusinesshuman activitiesasymmetry030217 neurology & neurosurgeryDiseases
researchProduct

Vitamin D and Parkinson's Disease.

2022

Vitamin D is a fat-soluble secosteroid, traditionally considered a key regulator of bone metabolism, calcium and phosphorous homeostasis. Its action is made possible through the binding to the vitamin D receptor (VDR), after which it directly and indirectly modulates the expression of thousands of genes. Vitamin D is important for brain development, mature brain activity and associated with many neurological diseases, including Parkinson’s disease (PD). High frequency of vitamin D deficiency in patients with Parkinson’s disease compared to control population was noted nearly twenty years ago. This finding is of interest given vitamin D’s neuroprotective effect, exerted by the action of neur…

125-dihydroxyvitamin DDisease progressionNutrition and DieteticsParkinson DiseaseVitaminsVitamin D DeficiencyNeuroprotectionCalcium DietaryParkinson’s diseaseHumansSettore MED/26 - NeurologiaNeurodegenerationVitamin DHumanFood ScienceNutrients
researchProduct

Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.

2019

With the rise of Next-Generation-Sequencing (NGS) methods, Micro-RNAs (miRNAs) have achieved an important position in the research landscape and have been found to present valuable diagnostic tools in various diseases such as multiple sclerosis or lung cancer. There is also emerging evidence that miRNAs play an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD) or Parkinson’s disease (PD). Apparently, these diseases come along with changes in miRNA expression patterns which led to attempts from researchers to use these small RNA species from several body fluids for a better diagnosis and in order to observe disease progression. Additionally, it…

610 Medical sciencesmicro-RNAsneurodegenerationParkinson’s disease610 Medizingut microbiomeAlzheimer’s diseaselcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroscienceOriginal Researchcrosstalklcsh:RC321-571Frontiers in neuroscience
researchProduct

PINK1: a critical protein kinase in the molecular mechanisms involved in Cancer and Parkinson's disease

2012

El cáncer y la enfermedad de Parkinson (PD) son dos enfermedades en las que el mecanismo pato- fisiológico final no está completamente definido. Datos epidemiológicos indican que los pacientes con PD poseen bajo riesgo de cáncer, con la excepción de melanoma maligno y cánceres de piel, tiroides y mama, lo que sugiere una conexión funcional entre PD y cáncer. Apoyando esta conexión, la desregulación de la homeostasis mitocondrial es una característica importante en la patogénesis de ambas enfermedades. Recientemente, varios genes asociados a PD, tales como Parkin, LRRK2, DJ-1, y PINK1, han sido propuestos como moduladores de procesos cancerígenos. Mutaciones en el gen de PINK1 están asociada…

:CIENCIAS DE LA VIDA::Bioquímica [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Biología molecularPINK1proliferationUNESCO::CIENCIAS DE LA VIDA::Bioquímicainvasion:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]mitochondriacell deathmitophagySer/Thr kinaseparkinson's diseaseoxidative stresscancercell cyclemitochondrial homeostasis
researchProduct

New prospective in treatment of Parkinson's disease: Studies on permeation of ropinirole through buccal mucosa

2012

The aptitude of ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson's disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using limonene or by application of electric fields. Absorption improvement was accompanied by the …

Absorption (pharmacology)IndolesTime FactorsSwinePharmaceutical SciencePharmacologyModels BiologicalPermeabilityAntiparkinson AgentsBuccal delivery Ropinirole Parkinson's disease Absorption enhancement Porcine buccal mucosaDrug Delivery SystemsElectricityCyclohexenesmedicineAnimalsAdjuvants PharmaceuticIontophoresisTerpenesChemistryMouth MucosaAdministration BuccalParkinson DiseasePenetration (firestop)Buccal administrationIontophoresisPermeationRopiniroleMembraneSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFeasibility StudiesLimoneneEx vivomedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Age at menopause predicts age at onset of Parkinson's disease.

2006

We investigated the association between age at onset of Parkinson's disease (PD) and fertile life characteristics in 145 women. Linear regression analyses showed a significant correlation between age at PD onset and age at menopause (P = 0.003), between age at PD onset and fertile life duration (P = 0.008), and a nonsignificant correlation between PD onset and cumulative duration of pregnancies (P = 0.23). These results support the possible role of estrogens in PD.

AdultAgingmedicine.medical_specialtyParkinson's diseasePhysiologyDiseaseRisk AssessmentCentral nervous system diseaseDegenerative diseasefertile lifePregnancyRisk FactorsInternal medicineage at menopausemedicineHumansAge of OnsetRisk factorAgedAged 80 and overPregnancybusiness.industryParkinson DiseaseMiddle Agedmedicine.diseaseMenopauseEndocrinologyNeurologyParkinson’s diseaseLinear ModelsSettore MED/26 - NeurologiaFemalewomenNeurology (clinical)MenopauseAge of onsetbusiness
researchProduct

Effects of Dual-Task Group Training on Gait, Cognitive Executive Function, and Quality of Life in People With Parkinson Disease: Results of Randomize…

2020

The aims of this study were to analyze the effects of a dual-task group program, to compare it with the effects of a single-task group program, and to analyze the effects of functional secondary tasks.Single-blind randomized controlled trial.University laboratory and a rehabilitation gym at a health center.Patients (N=40) with a diagnosis of Parkinson disease (mean age, 66.72y; age range, 44-79y) with Hoehn and Yahr stage I to III who were on medication were randomized to either a group with dual-task training or a group with single-task training (only gait).Both interventions involved 20 sessions lasting 1 hour each and conducted twice a week. Dual-task training included walking exercises …

AdultMale030506 rehabilitationmedicine.medical_specialtymedicine.medical_treatmentPsychological interventionPhysical Therapy Sports Therapy and Rehabilitationbehavioral disciplines and activitieslaw.invention03 medical and health sciencesExecutive Function0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled trialMultivariate analysis of varianceQuality of lifelawTask Performance and AnalysismedicineHumansSingle-Blind MethodEffects of sleep deprivation on cognitive performanceGaitAgedRehabilitationbusiness.industryRehabilitationCognitionParkinson DiseaseMiddle AgedGaitExercise TherapyTreatment OutcomePsychotherapy GroupQuality of LifeFemale0305 other medical sciencebusinesspsychological phenomena and processes030217 neurology & neurosurgeryArchives of physical medicine and rehabilitation
researchProduct

Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study

2022

AbstractThe association between dyslipidemia and cognitive performance in Parkinson’s disease (PD) patients still needs to be clarified. Aim of the study was to evaluate the presence of possible associations between serum lipids fractions and executive dysfunction also exploring the sex-specific contribute of lipids level on cognition. Patients from the PACOS cohort, who underwent a complete serum lipid profile measures (total cholesterol-TC, low-density lipoprotein cholesterol-LDL, high-density lipoprotein cholesterol-HDL and triglycerides-TG) were selected. Adult Treatment Panel III guidelines of the National Cholesterol Education Program were used to classify normal/abnormal lipid fracti…

AdultMaleCholesterol HDLParkinson DiseaseCholesterol LDLMiddle AgedLipidsExecutive functionsPsychiatry and Mental healthCholesterolNeurologyParkinson’s diseaseHumansFemaleSettore MED/26 - Neurologialipids (amino acids peptides and proteins)Neurology (clinical)TriglyceridesBiological PsychiatryAgedJournal of Neural Transmission
researchProduct

The assessment of functional ability in patients with Parkinson's disease: the PLM-test and three clinical tests.

1997

This study assesses functional ability of Parkinson's disease (PD) patients by means of an objective movement analysis (the PLM-test) and three clinical tests. The correlation between the tests was also studied. The main object of this study was to detect and measure relevant disabilities in Parkinson's disease to obtain a clinical test battery.

AdultMaleClinical testsmedicine.medical_specialtyActivities of daily livingParkinson's diseasePosturePhysical Therapy Sports Therapy and RehabilitationDiseaseDisability EvaluationPhysical medicine and rehabilitationActivities of Daily LivingmedicineHumansFunctional abilityGaitPostural BalancePhysical Therapy ModalitiesAgedAged 80 and overAnalysis of VarianceParkinson DiseaseMiddle Agedmedicine.diseaseGaitTest (assessment)Physical therapyFemaleAnalysis of variancePsychologyLocomotionPsychomotor PerformancePhysiotherapy research international : the journal for researchers and clinicians in physical therapy
researchProduct